用于软组织肉瘤的化疗药物:一篇综述
1Department of Orthopedics, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
Frontiers in pharmacology
|August 28, 2023
概括
本综述详细介绍了晚期软组织瘤 (STSs) 的化疗药物疗效. 人环素是关键的,而其他药物,如伊福斯法米德和纳税,根据STS亚型表现出不同的有效性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 癌症研究 癌症研究
背景情况:
- 软组织肉瘤 (STSs) 很少见,但可能进展到晚期,需要有效的化疗.
- 对于高级的STS,特别是多线或组合治疗,选择合适的化疗方案仍然具有挑战性.
- 目前的治疗指南要求对各种STS组织学亚型进行细化.
研究的目的:
- 综合审查各种化疗药物在治疗晚期STS中的疗效.
- 描述不同STS亚型的特定药物的当前状态和敏感性.
- 提供选择多线化疗药物的参考资料,用于延长存活期的晚期STS患者.
主要方法:
- 对STS中化疗药物疗效的现有文献进行系统审查.
- 对不同STS组织学亚型中药物活性的分析.
- 收集关于第一线和后续线治疗选择的数据.
主要成果:
- 人环素是先进的STS的主要全身治疗方法.
- 伊福斯法米德,特拉贝克特丁,格姆西塔,纳税素,达卡巴和埃里布林显示出显著的活性.
- 葡萄酒类化合物对特定亚型 (例如,拉布多米索尔科马,尤英肉瘤) 有效,但对其他亚型 (例如,拉布多米索尔科马,尤英肉瘤) 效果较差. 其他药物表现出有限的疗效.
结论:
- 对于高级STS的化疗选择必须根据特定的组织学亚型量身定制.
- 对多线疗法的细微方法对于改善高级STS的结果至关重要.
- 本综述是临床医生在优化晚期STS患者的化疗选择时的指南.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
01:10Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
01:27Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K